《柳叶刀糖尿病内分泌》2025修订版；13: 374 - 83

IF 41.8 1区医学 Q1 ENDOCRINOLOGY & METABOLISM

The Lancet Diabetes & Endocrinology Pub Date : 2025-04-30 DOI:10.1016/s2213-8587(25)00128-7

{"title":"《柳叶刀糖尿病内分泌》2025修订版；13: 374 - 83","authors":"","doi":"10.1016/s2213-8587(25)00128-7","DOIUrl":null,"url":null,"abstract":"Orandi BJ, Chen Y, Li Y, et al.. GLP-1 receptor agonists in kidney transplant recipients with pre-existing diabetes: a retrospective cohort study. Lancet Diabetes Endocrinol 2025; 13: 374–83—In figure 1 and table 2 of this Article, precise data in cells with 11 or fewer patients should have been suppressed. These corrections have been made to the online version as of April 29, 2025.","PeriodicalId":48790,"journal":{"name":"The Lancet Diabetes & Endocrinology","volume":"12 1","pages":""},"PeriodicalIF":41.8000,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Correction to Lancet Diabetes Endocrinol 2025; 13: 374–83\",\"authors\":\"\",\"doi\":\"10.1016/s2213-8587(25)00128-7\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Orandi BJ, Chen Y, Li Y, et al.. GLP-1 receptor agonists in kidney transplant recipients with pre-existing diabetes: a retrospective cohort study. Lancet Diabetes Endocrinol 2025; 13: 374–83—In figure 1 and table 2 of this Article, precise data in cells with 11 or fewer patients should have been suppressed. These corrections have been made to the online version as of April 29, 2025.\",\"PeriodicalId\":48790,\"journal\":{\"name\":\"The Lancet Diabetes & Endocrinology\",\"volume\":\"12 1\",\"pages\":\"\"},\"PeriodicalIF\":41.8000,\"publicationDate\":\"2025-04-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Lancet Diabetes & Endocrinology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/s2213-8587(25)00128-7\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet Diabetes & Endocrinology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/s2213-8587(25)00128-7","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

摘要

胡文杰，陈勇，李勇，等。GLP-1受体激动剂在既往糖尿病肾移植受者中的应用：一项回顾性队列研究柳叶刀糖尿病内分泌2025；[13:374 - 83]在本文的图1和表2中，11例或更少患者的细胞的精确数据应该被抑制。这些更正已于2025年4月29日对在线版本进行了修改。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Correction to Lancet Diabetes Endocrinol 2025; 13: 374–83

Orandi BJ, Chen Y, Li Y, et al.. GLP-1 receptor agonists in kidney transplant recipients with pre-existing diabetes: a retrospective cohort study. Lancet Diabetes Endocrinol 2025; 13: 374–83—In figure 1 and table 2 of this Article, precise data in cells with 11 or fewer patients should have been suppressed. These corrections have been made to the online version as of April 29, 2025.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

The Lancet Diabetes & Endocrinology ENDOCRINOLOGY & METABOLISM-

CiteScore

61.50

自引率

1.60%

发文量

371

期刊介绍： The Lancet Diabetes & Endocrinology, an independent journal with a global perspective and strong clinical focus, features original clinical research, expert reviews, news, and opinion pieces in each monthly issue. Covering topics like diabetes, obesity, nutrition, and more, the journal provides insights into clinical advances and practice-changing research worldwide. It welcomes original research advocating change or shedding light on clinical practice, as well as informative reviews on related topics, especially those with global health importance and relevance to low-income and middle-income countries. The journal publishes various content types, including Articles, Reviews, Comments, Correspondence, Health Policy, and Personal Views, along with Series and Commissions aiming to drive positive change in clinical practice and health policy in diabetes and endocrinology.